Cover
Cover | Oct. 23, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Oct. 23, 2022 |
Entity Registrant Name | PhaseBio Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38697 |
Entity Tax Identification Number | 03-0375697 |
Entity Address, Address Line One | 1 Great Valley Parkway |
Entity Address, Address Line Two | Suite 30 |
Entity Address, City or Town | Malvern |
Entity Address, State or Province | PA |
Entity Address, Postal Zip Code | 19355 |
City Area Code | 610 |
Local Phone Number | 981-6500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | PHAS |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Amendment Flag | false |
Entity Central Index Key | 0001169245 |